| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 09/13/2023 |
3. Issuer Name and Ticker or Trading Symbol
NORDSTROM INC [ JWN ] |
|||||||||||||
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
| |||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Common Stock | 105,149(1) | D | |
| Common Stock | 2,656 | I | By 401(k) Plan, per Plan statement dated 8/31/2023 |
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Employee Stock Option (right to buy) | (2) | 03/03/2024 | Common Stock | 2,680 | 57.16 | D | |
| Employee Stock Option (right to buy) | (2) | 02/24/2025 | Common Stock | 2,790 | 75.23 | D | |
| Employee Stock Option (right to buy) | (2) | 02/28/2026 | Common Stock | 3,540 | 51.32 | D | |
| Employee Stock Option (right to buy) | (3) | 03/04/2031 | Common Stock | 6,121 | 35.52 | D | |
| Employee Stock Option (right to buy) | (4) | 03/03/2032 | Common Stock | 8,253 | 25.68 | D | |
| Employee Stock Option (right to buy) | (5) | 03/06/2033 | Common Stock | 8,397 | 19.63 | D | |
| Explanation of Responses: |
| 1. Representing 32,872 shares of Common Stock and 72,277 Restricted Stock Units ("RSUs"). Upon vesting, each RSU converts to one share of Common Stock. Unvested RSUs consist of: 2,880 RSUs granted on 3/9/2020 and vesting on 3/10/2024; 3,892 RSUs granted on 3/4/2021 and vesting in two equal installments on each of 03/10/2024 and 3/10/2025; 8,299 RSUs granted on 3/3/2022 and vesting in three equal installments on each of 3/10/2024, 3/10/2025 and 3/10/2026; 45,147 RSUs granted on 5/26/2022 and vesting in two equal installments on each of 6/10/2024 and 6/10/2025; and 12,059 RSUs granted on 3/6/2023 and vesting in four equal installments on 3/10/2024, 3/10/2025, 3/10/2026 and 3/10/2027. |
| 2. Fully vested. |
| 3. Vesting 50% on 3/10/2024 and 50% on 3/10/2025. |
| 4. Vesting 50% on 3/10/2025 and 50% on 3/10/2026. |
| 5. Vesting 50% on 3/10/2026 and 50% on 3/10/2027. |
| Remarks: |
| /s/ Brian B. DeFoe, Attorney-in-Fact for Fanya Chandler | 09/25/2023 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||